Abstract
This study is the first report of a compound which is equal in efficacy to gamma-aminobutyric acid (GABA) at the nematode Ascaris muscle GABA-receptor. The GABA-receptor at the Ascaris muscle cell which mediates a membrane hyperpolarization and muscle relaxation has eluded classification. The structure-activity profile of this receptor is not typical of GABAA or GABAB-receptors. Here we report that the isothiouronium compound ZAPA is as potent as GABA at this receptor. This finding has important implications for the characterization of the Ascaris GABA-receptor and the design of novel anthelmintics.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allan R. D., Dickenson H. W., Hiern B. P., Johnston G. A., Kazlauskas R. Isothiouronium compounds as gamma-aminobutyric acid agonists. Br J Pharmacol. 1986 Jun;88(2):379–387. doi: 10.1111/j.1476-5381.1986.tb10214.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
 - Del Castillo J., De Mello W. C., Morales T. Inhibitory action of gamma-aminobutyric acid (GABA) on Ascaris muscle. Experientia. 1964 Mar 15;20(3):141–143. doi: 10.1007/BF02150701. [DOI] [PubMed] [Google Scholar]
 - Martin R. J. Electrophysiological effects of piperazine and diethylcarbamazine on Ascaris suum somatic muscle. Br J Pharmacol. 1982 Oct;77(2):255–265. doi: 10.1111/j.1476-5381.1982.tb09294.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
 - Martin R. J. The gamma-aminobutyric acid receptor of Ascaris as a target for anthelmintics. Biochem Soc Trans. 1987 Feb;15(1):61–65. doi: 10.1042/bst0150061a. [DOI] [PubMed] [Google Scholar]
 - Nistri A., Constanti A. Pharmacological characterization of different types of GABA and glutamate receptors in vertebrates and invertebrates. Prog Neurobiol. 1979;13(2):117–235. doi: 10.1016/0301-0082(79)90016-9. [DOI] [PubMed] [Google Scholar]
 - Wann K. T. The electrophysiology of the somatic muscle cells of Ascaris suum and Ascaridia galli. Parasitology. 1987 Jun;94(Pt 3):555–566. doi: 10.1017/s003118200005589x. [DOI] [PubMed] [Google Scholar]
 
